Who Cut Down the Cherry Tree?
All Situation Room examples are constructed and not descriptions of actual events.

Published on: February 6, 2026
Walter Routh
Share This Article with the Stability Community!
What is the stability situation?
I feel like George Washington deciding if I should admit to cutting down the cherry tree or not. We were just notified of a regulatory audit of our vaccine stability program scheduled in five days. We’re in a conundrum of whether to proactively bring the auditors attention to a systemic failure of our environmental monitoring system where the system crashed two weeks ago and stopped collecting data for nearly 18 hours with no alarms and no backup recorders at the time.
We’ve had numerous meetings and spent many hours investigating but are not satisfied with IT’s and HVAC maintenance group’s explanation of the event. We don’t believe we have enough information to implement a true corrective action. IT says it was a one off, extremely rare occurrence that will never happen again. The HVAC group says that there are no issues since the air handlers functioned as designed during the deviation period and there is no evidence that any actual environmental outage occurred. To top it all off, the event highlights significant shortcomings in our program.
Since it’s still an open investigation should we hope for the best—that the auditors will not discover the outage? Or should we notify them in the opening meeting or soon after that we have an unresolved outage and disclose our findings so far?
How should this be resolved?
You should definitely “hope for the best.” Our practice is that when inspectors pre-request investigations and deviations for their audit we only include closed investigations. In my experience, auditors rarely get into such depth of scrutiny that they would directly observe the 18-hour data gap on their own, so the risk of detection is much more appealing than the possible 483 resulting from your voluntary disclosure.
We Want to Hear Your Thoughts!
January 11, 2026
A small biopharma company is facing exposure to a FDA audit after inspectors surprisingly showed up at the CDMO handling most of their storage and testing. What can they do to reduce their risk of getting a 483?
November 28, 2025
Time marches on and so do expectations for quality and agility. Can our outdated be updated?
November 1, 2025
When samples are placed in the wrong chamber for a study, is it the end of the road or are there some ways it can be salvaged?
Share your questions and experiences
A stabilitarian encounters new situations every day. StabilityHub’s discussion forums give Stabilitarians an opportunity to ask questions and offer solutions to specific scenarios. Join in the conversations with other Stabilitiarians and share your knowledge!
A stabilitarian encounters new situations every day. StabilityHub’s discussion forums give Stabilitarians an opportunity to ask questions and offer solutions to specific scenarios. Join in the conversations with other Stabilitiarians and share your knowledge!




